WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use. (2022)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2022.02.040

PubMed Identifier: 35184927

Publication URI: http://europepmc.org/abstract/MED/35184927

Type: Journal Article/Review

Volume: 40

Parent Publication: Vaccine

Issue: 26

ISSN: 0264-410X